Deep anterior lamellar lamellartransplantation (DALK)

clinical manifestation of stromal rejection

Authors

  • Elisa Constanza Calvo Braun Consultorio Oftalmológico Dra Elisa Constanza Calvo Braun

DOI:

https://doi.org/10.70313/2718.7446.v18.n1.407

Keywords:

DALK, lamellar corneal graft, immunologic rejection

Abstract

Deep anterior lamellar lamellar transplantation (DALK) is an interesting surgical option that eliminates the possibility of endothelial allograft rejection, which is the main cause of graft failure after penetrating keratoplasty1.

Downloads

Download data is not yet available.

Author Biography

  • Elisa Constanza Calvo Braun, Consultorio Oftalmológico Dra Elisa Constanza Calvo Braun

    Consultorio Oftalmológico Dra Elisa Constanza Calvo Braun; Centro Oftalmológico Metropolitano. Ciudad Autónoma de Buenos Aires. Argentina.

References

Hos D, Matthaei M, Bock F et al. Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation. Prog Retin Eye Res. 2019; 73: 100768. doi:10.1016/j.preteyeres.2019.07.001

Kasamatsu H, Yamaguchi T, Yagi-Yaguchi Y et al. Incidence and clinical features of immunologic rejection after deep anterior lamellar keratoplasty. Cornea. 2024; 43(8): 1008-1014. doi:10.1097/ICO.0000000000003444

Published

2025-03-28

Issue

Section

Imágenes en oftalmología

How to Cite

[1]
2025. Deep anterior lamellar lamellartransplantation (DALK): clinical manifestation of stromal rejection. Oftalmología Clínica y Experimental. 18, 1 (Mar. 2025), e120-e122. DOI:https://doi.org/10.70313/2718.7446.v18.n1.407.

Similar Articles

1-10 of 288

You may also start an advanced similarity search for this article.